Suchergebnisse - "Dogné, Jean-Michel"

PubPharm (28)

1

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays

enthalten in: Thrombosis journal | 2014

von Douxfils, J. | Tamigniau, A. | Chatelain, B. | +3

2

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays

enthalten in: Thrombosis journal | 2014

von Douxfils, J. | Tamigniau, A. | Chatelain, B. | +3

3

Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation : a prospective study

enthalten in: The Annals of pharmacotherapy | 2014

von Larock, A. | Mullier, F. | Sennesael, A. | +5

CommentIn: Ann Pharmacother. 2015 Jan;49(1):154. - PMID 25524932

4

Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation

enthalten in: The annals of pharmacotherapy | 2014

von Larock, A. | Mullier, F. | Sennesael, A. | +5

5

Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia

enthalten in: Thrombosis research | 2014

von Gheldof, D. | Chatelain, C. | Dogné, J. | +1

CommentOn: Thromb Res. 2014 Mar;133(3):303-5. - PMID 24439676

6

Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia

enthalten in: Thrombosis research / Supplement | 2014

von Gheldof, D. | Chatelain, C. | Dogné, J. | +1

7

Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department

enthalten in: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis | 2014

von Mullier, F. | Vanpee, D. | Jamart, J. | +6

8

Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Journal of the American Heart Association | 2014

von Douxfils, J. | Buckinx, F. | Mullier, F. | +6

9

Proactively managing the risk of marketed drugs : experience with the EMA Pharmacovigilance Risk Assessment Committee

enthalten in: Nature reviews. Drug discovery | 2014

von Arlett, P. | Portier, G. | de Lisa, R. | +6

10

Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee

enthalten in: Nature reviews / Drug discovery | 2014

von Arlett, P. | Portier, G. | de Lisa, R. | +6